Log In
BCIQ
Print this Print this
 

Hexavac

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionVaccine against diphtheria, tetanus, pertussis, poliomyelitis virus, hepatitis B virus (HBV) and Haemophilus influenzae
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentMarketed
Standard IndicationBacterial infection
Indication DetailsPrevent diphtheria, tetanus, pertussis, hepatitis B virus (HBV), polio virus and Haemophilus influenzae type B (Hib) in children
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/08/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today